Optimizing the Care of Patients With Higher-Risk Myelofibrosis
Higher-risk myelofibrosis is a complex disease requiring individualized care. At JADPRO Live 2024, presenters reviewed pathophysiology, diagnosis, risk assessment, and symptom management strategies for myelofibrosis. They also explored treatment options for higher-risk myelofibrosis, balancing benefits and risks while considering patient preferences and goals.
Authors
- MPAS Julie Huynh-Lu
Publication Details
- Journal
- Journal of the Advanced Practitioner in Oncology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.6004/jadpro.2025.16.2.16
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00